ArticleFrontiers in pharmacology2026
Changes in youth public psychiatric service utilization during the COVID-19 pandemic in Italy: an observational study.
Article in Frontiers in pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Social restrictions due to the COVID-19 pandemic have impacted the lives of children and adolescents worldwide. In this study, we aim to evaluate the impact of lockdown periods implemented in Italy during the SARS-CoV-2 waves on the mental health of minors. Methods: A population-based study using Italian healthcare administrative databases was conducted. Weekly time series of emergency department (ED) accesses/hospitalizations for psychiatric disorders, along with the incidence of antidepressant/antipsychotic (AD/AP) drug users, were defined from 1 January 2017 to 31 December 2022. An interrupted time-series analysis was used to assess the effect of lockdowns on the observed outcomes. The results were reported as incidence rate ratios (IRRs) with their respective 95% confidence intervals (95% CIs). Results: The first lockdown was associated with an abrupt reduction in both the incidence of AD/AP use (IRR = 0.49; 95% CI = 0.34-0.72) and ED accesses/hospitalizations for psychiatric disorders (IRR = 0.15; 95% CI = 0.10-0.23) compared to the pre-pandemic period. The incidence of AD/AP medication users showed a marked increase in both the post-first lockdown period (IRR = 2.48; 95% CI = 1.71-3.59) and the post-second lockdown period (IRR = 1.26; 95% CI = 1.07-1.48). ED accesses/hospitalizations showed a marked increase in the post-first lockdown period (IRR = 1.90; 95% CI = 1.40-2.59). Conclusion: The different lockdowns implemented during the COVID-19 outbreaks markedly affected the mental health of minors, as suggested by the increased use of AD/AP medications, which can be considered a proxy of diseases. The increased use of AD/AP medications in the observed period calls for interventions to improve the mental health of the population. These findings highlight the need to ensure effective public health interventions to be prepared for future crises.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.